Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medmen Enterprises Inc C.MMEN


Primary Symbol: MMNFQ

MedMen Enterprises Inc. is a retail cannabis company with an operational footprint in California, Nevada, Illinois, Massachusetts, and New York. The Company offers a robust selection of high-quality products, including MedMen-owned brands MedMen Red, Moss and LuxLyte, through its premium retail stores, proprietary delivery service, as well as curbside and instore pickup. MedMen Buds, a loyalty program, provides access to promotions, product drops and content. It produces and curates the consumer product assortment for retail operations in its local communities with services and engaging in-store experience, combined with reward, delivery, and e-commerce programs. It also offers buds rewards, where buds members earn points with every purchase, plus exclusive access to drops and deals. The Company also provides gift cards.


GREY:MMNFQ - Post by User

Bullboard Posts
Comment by JesseBon Sep 09, 2019 12:39am
81 Views
Post# 30107383

RE:Upcoming DOJ News

RE:Upcoming DOJ NewsMy guess is that medmen, harvest health, curaleaf, and tulieve having similar guidance of near 1 billion fy2020 would get them close to 4 billlion market cap (cura is there already). I kind of expect the other 3 to double from their current valuations, unless Aurora has a pullback. Aurora is sitting at 8 billion with similar guidance but with full production capacity if they can sell it all they can bring in close to 4 billion annually. The MSOs will have to build or acquire ALOT to get to those levels so with similar near term guidance I dont think they should get the same valuation as the big LP.
BigMoo9055 wrote: Anyone have any opinions on where stock will land once the DOJ rules on the pending acquisition of Pharmacannis in the US ? 


Bullboard Posts